REFERENCES

REFERENCES:

• ADA: American Diabetes Association. Clinical Practice Recommendations-2004. Diabetes Care 2004; 27: SI-SI43

• Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172(7):899-905

• Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of

nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J HepatoI2005;42: 132-138

• Agarwal SR, Malhotra V, Sakhuja P et al. Clinical, Biochemical and Histological Profile of Nonalcoholic Steatohepatitis. Indian J Gastro. 200 I; 20: 183-186.

• Albu JB, Kovera AJ, Allen L et al. Independent association of insulin

resistance with larger amounts of intermuscular adipose tissue and a greater

acute insulin response to glucose in African American than in white

nondiabetic women. Am J Clin Nutr. 2005; 82(6):1210-7.

• Altomonte J .. Fat depot-specific expression of adiponectin is impaired in . zucker fatty rats. Metabolism· 2003; 52: 958 - 963

• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231

• Arita Y, Kihara S, Ouchi N et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB-Binding Protein and Regulates Growth Factor-Induced Common Postreceptor Signal in

Vascular Smooth Muscle Cell. Circulation.2002; 1 05 :2893-2898

• Arita. Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose specific protein, adiponectin, in obesity. Biochem Biophys Res Commun.1999; 257: 79-'83.

• Astrup A, Finer N. Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes Rev 2000; 1 :57-59.

• Aygun C, Kocaman 0, Senturk O. Adiponectin: is it a novel treatment

modality to alleviate liver injury in non-alcoholic fatty liver disease

(NAFLD)? Med Hypotheses. 2008;70(2):457-8

• Basso LV, Havel RJ. Hepatic metabolism of free fatty acids in nonnal and

diabetic dogs. J Clin Invest. 1970; 49: 537-547

• Bedogni G, MiglioIi L, Masutti F et al. Incidence and natural course of fatty

liver in the general population: The Dionysos study. Hepatology

2007;46(5): 1387-91

• Bedossa P, Moucari R, Chelbi E et al. Evidence for a role of nonalcoholic

steatohepatitis in hepatitis C: a prospective study. Hepatology. 2007;

46(2):380-7.

132

• Bjursel1 M, Ahnmark A, Bohlooly-YM et al. Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism.Diabetes 2007; 56:583-593.

• Bracken CP, Whitelaw ML,. Peet DJ. Activity of hypoxia-inducible factor 2alpha is regulated by association with the NF-kappaB essential modulator. J BioI Chern. 2005 Apr 8;280(14): 14240-51

• Brea A, Mosquera D, Martin E et al. Non'alcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Bioi 2005; 25: 1045-1050

• Brunt EM et al. Non Alcoholic Steato Hepatitis: A proposal for grading and staging the histological lesions. Am. J Gastroenterol 1994; 94:2467-2474.

• Bugianesi E, McCullough AJ, Marchesini G. Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease. Hepatology 2005;42:987-1000.

• Bugianesi E, Pagotto U, Manini R et al. Plasma adiponectin in nonalcoholic fatty liver disease is related to hepatic insulin resistance and hepatic fat content, Not to Liver Disease Severity. J Clin Endocrinol Metab. 2005; 90:3498-3504.

• Burim RV, CanaJIe R, Martinelli Ade L, Takahashi CS. Polymorph isms in glutathione S-transferases GSTM I, GSTT I and GSTP I and cytochromes P450 CYP2E 1 and CYP lA 1 and susceptibility to cirrhosis or pancreatitis in

alcoholics. Mutagenesis. 2004; 19(4):291-8.

• Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol. 1998; 15:246-258

• Celle G, Savarino V,Picciotto A et al. Is hepatic ultrasonography a valid tool to liver biopsy? Dig.Dis.Sci. 1988; 33:467-71.

• Chalassani N, Crabb OW, Cummings OW et al. Does leptin playa role in the pathogenesis of human nonalcoholic fatty liver disease? Am.JGastroenterol 2003;98:2771-2776.

• Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84:2329-2335

• Chen B, Lam KS, Wang Y et al. Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-l independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun. 2006; 341 (2):549-56.

• Chen H, Montagnani M, Funahashi T et al. Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells. J. BioI. Chern. 2003; 278:45021-45026.

• Chitturi .S, Farrell GC, Jacob George et al: Nonalcoholic steatohepatitis in Asia Pacific region: Future shock? J.Gastroenterol. Heptol. 2004; 19,368-374

133

• Chitturi S, Farrel G, Frost L, Kriketos A, Lin R, Fung C et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 2002; 36:403-409.

• Choudhury J, Sanyal A1. Clinical aspects of fatty liver disease; SeminLiver Dis 2004; 24(4):349-362 .

• Chudek J, Wiecek A. Adipose tissue, inflammation and endothelial dysfunction. Pharmacological Reports (Suppl.) 2006;58:81-88

• Cianflone K, Maslowska M, Sniderman AD: Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Bioi 10:31-41, 1999

• Cladwell SH et al; Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-69

• Clark 1M, Diehl AM, Nonalcoholic Fatty Liver Disease: An Under recognized Cause of Cryptogenic Cirrhosis JAMA 2003; 289: 3000-3004

• Comuzzie AG, Funahashi T, Sonnenberg el al. The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome. J Clin Endocrinol Metab 86: 4321-4325,2001

• Contos MJ, W. Cales, R K. Sterling, et al. Development of Nonalcoholic Fatty Liver Disease After Orthotopic Liver Transplantation for Cryptogenic Cirrhosis Liver Transplantation,200 I ;7(4): 363-373

• Corpet F. Multiple sequence alignment with hierarchical clustering. Nuc!. Acids Res. 1988; 16 (22): 10881-10890

• Danforth E Jr. Failure of adipose tissue differentiation causes type II diabetes mellitus? Nat. Genet. 2000; 26: 13.

• Day. C. Metabolic syndrome, or what you will: definitions and epidemiology. Diabetes Vasc Dis Res 2007;4:32-8

• Despres, 1. P. Is visceral obesity the cause of the metabolic syndrome? Ann. Med. 38, 52-63 (2006).

• Evan D. Rosenl & Bruce M. Spiegelman. Adipocytes as regulators of energy balance and glucose homeostasis.Nature 2006 ;444:847-853.

• Farid FC. Minireview: Obesity and LipOdystrophy-Where Do the Circles Intersect? Endocrinology 149:925-934,2008

• Farrell GC, Larter CZ. Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis. HEPATOLOGY 2006; 43:S99-S1l2.

• Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and Nutritional Considerations in Nonalcoholic Fatty Liver. Hepatology 2000;32:3-10

• Fukuhara A, Matsuda M, Nishizawa M et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430, 2005

• Garg A. Acquired and Inherited Lipodystrophies. N Engl J Med 2004;350: 1220-1234

• Gavrilova 0, Marcus-Samuels B, Graham D et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000;

105: 271-278

134

• Gil-Campos M , Canete ,Gil A. Adiponectin, the missing link in insulin

resistance and obesity. Clinical Nutrition, Volume 23 ,Issue 5 :963 - 974

• Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.

• Haluzik M, Parizkova J, Haluzik MM. Adiponectin and Its Role in the Obesity-Induced Insulin Resistance and Related Complications. Physiol. Res. 2004;53: 123-129

• Hamaguchi M, Kojima T, Takeda N et al. The Metabolic Syndrome as a

Predictor of Nonalcoholic Fatty Liver Disease. Ann Intern Med. 2005; 143:722-728

• Hara K, Boutin P, Moriet Y et al . Genetic Variation in the Gene Encoding

Adiponectin Is Associated With an Increased Risk of Type 2 Diabetes in the Japanese Population. Diabetes 2002; 51: 536-540

• Hardie GO. Minireview: The AMP-Activated Protein Kinase Cascade:The Key Sensor of Cellular Energy Status. Endocrinology 2003; 144: 5179-5183

• Havel PJ. Update on Adipocyte Hormones: Regulation of Energy balance

and carbohydrate(lipid metabolism. Diabetes 2004; 53 (suppl.1 ):S 143-S 151.

• Horikoshi M, Hara K, Ohashi J et al. A Polymorphism in the AMPK2

Subunit Gene Is Associated With Insulin Resistance and Type 2 Diabetes in

the Japanese Population. Diabetes 55: 919-923

• Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest.2002; 109:1125-1131

• Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM 1994.Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91 :4854-4858 , .

• Hui JM, Hodge A,Farrel GC, Kench JG, Kriketos A, George 1. Beyond Insulin Resistance in NASH: TNF-a or Adiponectin? Hepatology 2004; 40:46-54.

• Ikeda K, Maegawa H, Ugi S. Transcription factor activating enhancer­

binding protein-2beta. A negative regulator of adiponectin gene expression.J BioI Chem. 2006;281(42):31245-53

• Iwaki M, Matsuda M, Maeda Net al. Induction of adiponectin a fat derived

antidiabetic and anti-atherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655-1663.

• Jackson S, Kler RS, Bartlett K et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992;90: 1219-1225 [PMID: 1401059]

• Kadowaki T, Sekikawa A, Murata K. et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist

circumference in a population-based study. Int. 1. Obes. (Lond.) 2006;30,

1163-1165.

135

• Kagansky N, Levy S, Keter D et al. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients. Liver Int 2004;24:588-594

• Kahn CR, Weir GC, King GL et al. Joslin's Diabetes Mellitus. 14th Ed. Lippincott Williams and Wilkins.

• Kahn R, Buse J, Frrrannini E, Stem M. The Metabolic Syndrome: Time for a Critical Appraisal: joiI1t statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304

• Kanemasa K, Sumida Y. Role of liver biopsy in the diagnosis of NASH. Nippon Rinsho. 2006; 64(6): 1119-25

• Katzmarzyk PT, Church TS, Janssen I, Ross R. The Importance of Waist Circumference in the Definition of Metabolic syndrome. Diabetes Care 29:404-409,2006

• Kim HB, Kong M, Kim TM et al. NF A Tc4 and A TF3 Negatively Regulate Adiponectin Gene Expression in 3T3-Ll Adipocytes. Diabetes 2006;55: 1342-1352

• Kim KH, Shin HJ, Kim K et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP 1 and PP ARgamma. Gastroenterology. 2007; 132(5): 1955-67

• Kondo H, Shimomura I, Matsukawa Y et al. Association of Adiponectin Mutation With Type 2 Diabetes, A Candidate Gene for the Insulin resistance Syndrome. Diabetes 2002; 51 :2325-2328.

• Krentz AJ. Fortnightly Review: Insulin resistance.BMJ 1996;313: 1385-1389

• Kubota N, Terauchi Y, Yamauchi T, Kubota T et al: Disruption of adiponectin causes insulin resistance and neointimal fonnation. J BioI Chem 2002;277 :25863 -25866

• Kuinada M, Kihara S, Ouchi N et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-l through interleukin-l0 expression in human macrophages. Circulation.2004; 109, 2046-2049.

• Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered Fat Storage and Mobilization, in the Pathogenesis of Insulin Resistance and Type 2 Diabetes. Endocr Rev 2002,23:201-229

• Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev.2004; 36(3-4):51.1-29.

• Lindsay R, Funahashi T, Hanson R. Adiponectin and development of type 2 diabetes inthe Pima Indian population. The Lancet. 2003; 360 (9326):57-58

• Lonardo A, Carani C, CaruHi N et al.Endocrine NAFLD' a honnonocentric perspective of nonalcoholic fatty liver disease.1. Hepatol.2006; 44 : 1196-1207

• Machado M, Cortez-Pinto H. Non-alcoholic fatty liver disease and insulin

resistance. Eur J Gastroenterol Hepatol. 2005; 17:823-826

136

• Madan K, Batra Y, Gupta SD, Chander B, Anand Rajan KD, Tewatia MS, Panda SK, Acharya SK. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World 1 Gastroenterol 2006; 12(21): 3400-3405

• Mao X, Kikani CK, Riojas RA. APPL 1 binds to adiponectin receptors and mediates adiponectin signaling and function. Nat Cell BioI. 2006;8(5):516-23.

• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology'2003; 37:917-923.

• Marra F. Leptin and liver fibrosis: a matter of fact. Gastroenterology. 2002; 112:1529-1532.

• Marrero lA, Fontana RJ, Su GL, Conjeevaram HS, Emick OM, Lok ASF.NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36: 1349-1354.

• Matthews DR et al Homeostasis Model Assessment: insulin resistance and beta cell function from plasma FBS and insulin concentrations in man.

Diabetologia 198528:412-419.

• Medina J et al Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis. Diabetes Care 2004;27:2057-2066.

• Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponecti'n and resistin. Clin Chern 2004; 50(9): 1511-25.

• Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM. Correlation of Paired Liver Biopsies in Morbidly Obese Patients with Suspected Nonalcoholic Fatty Liver Disease. Hepatology. 2006;44:874-880

• Miller SA, Dykes DO, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res.1988; 16, 1215

• Mirbagheri SA, Rashidi A, Abdi S et al. Liver: an alarm for the heart? 2007 Liver International 27 (7), 891-894.

• Mishra A, Wasir JS, Pandey RM, An Evaluation of Candidate Definitions of the Metabolic Syndrome in Adult Asian. Indians , Diabetes Care 2005;28:398-403

• Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Current Science 2002; 83: 1483-1496.

• Mohan R, Heyman RA. Orphan nuclear receptor modulators. Curr Top Med Chern 2003;3: 1637-1647

• Mokdad, A. H .. et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2003.1. Am. Med. Assoc. 289, 76-79

137

• ..

•

•

•

Mori Y, Otabe S, Dina C et al. Genome-Wide Search for Type 2 Diabetes in Japanese Affected Sib-Pairs Confirms Susceptibility Genes on 3q, 15q, and 20q and Identifies Two New Candidate Loci on 7p and 11 p Diabetes 2002;51: 1247-1255.

Motoshima H" Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation a!1d superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun. 2004; 315, 264-271.

MUller C. Liver, alcohol and gender. Wi en Med Wochenschr. 2006; 156(19-20):523-6

Musso G, Gambino R, De Michieli F et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.Hepatology. 2008;47(4): 1167-77

• Naderali EK,Estadella D et al 'A fat enriched,glucose enriched diet markedly attenuates adiponectin mRNA levels in rat epididymal adipose tissue,Clinical Science.2003; 1 05,403-408 .

, Nakae J, Cao Y, Oki M et al. Forkhead transcription factor FoxO 1 in adipose tissues regulates energy storage and expenditure. Diabetes 2008; 57:563-576

• Natarajan R, Salloum FN, Fisher BJ et al. Hypoxia inducible factor-l upregulates adiponectin in diabetic mouse hearts and attenuates post­ischemic injuryJ Cardiovasc Phannacol. 2008 Feb;51(2): 178-87

• NCEP: Executive Summary of the Third Report of the' National Cholesterol Education Program Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497

• Nei M, Roychoudhury AK. Evolutionary relationships of human populations on a global scale Mol BioI Evol 1993,10: 927-943

• Ochi M, Osawa H, Hirota y et al. Frequency of the GIG Genotype of Resistin Single Nucleotide Polymorphism at -420 Appears to Be Increased in Younger-Onset Type 2 Diabetes. Diabetes 56: 2834-2838

• Okamoto Y, Kihara S, Ouchi N et al; Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2002; 1 06: 2767 -2770

• Ouchi N, Kihara S, Arita Yet al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP­dependent pathway. Circulation 2000; 102: 1296 -1301.

• Ouchi N, Kihara S, Arita Y et al. Novel Modulator for Endothelial Adhesion Molecules Adipocyte-Derived Plasma Protein Adiponectin. Circulation. 1999; 100:2473-2476.

• Ouchi N, Kihara S, Arita Y et al;Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103

:1057 -1063.

138

• Ouedraogo R, Gong Y, Berzins B et al.Adiponectin deficiency increases ~ ... .".;ti~u·k~~yte-end0tr.elium interactions via upregulation of endothelial cell

adhesion molec les in vivo. J Clin Invest. 2007;117(6):1718-26

• Paul Trayhum et aI, Physiological role of white adipose tissue as an endocrine and s cretory organ;Proc.of the Nutr.Soc.200 1 ;60,329-331

• Peake PW, She Y, Walther A et al. Adiponectin binds Clq and activates the classical path} ay of complement.Biochem. Biophys. Res. Commun. Biochem Bioph s Res Commun. 2008Mar 14;367(3):560-5.

• Petersen KF, efroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the

el.derly: pOSSi~t.· role in i~su~in resista~ce. ~cience 200~; 300: 1140-1142 • Pmcock S, ZI . et P. Flghtmg the 'dlabeslty' pandemic. Lancet 2006;; 368,

1643. .

• Qi. L, D~ria 1, Mans~n JE et al.~dip.onecti~ geneti.c variability, .plasma adlponectm, aFld cardIOvascular nsk m patients with type 2 dIabetes. Diabetes. 2006J; 55(5): 1512-6 .

. _-.*. -Qiatr t;Shao- 1. SIRT I Regulates Adiponectin Gene Expression through Foxol-C/Enhancer-binding Protein-a Transcriptional Complex. J BioI. Chern. 2006; 281 (52)39915-39924

• Quinn SF,Gosnik BB. Characteristic sonographic signs of hepatic fatty infiltration. AJR Am.J. Roentgenology. 1985; 145(4):753-5.

• Rajala MW, Obici S, Scherer PE et al. Adipose-derived resistin and gut derived resistin-like molecule-beta selectively impair insulin action on glucose production. J.Clin. Invest. 2003; Ill: 225-230.

• Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V: Metabolic syndrome in urban Asian Indian adults: a population study using modified ATP III criteria. Di~betes Res Clin Pract 2003; 60: 199-204

• Ratziu V, Bonyhay L, et al. Survival, liver failure, and hepatocellular carcinoma in. obesity-related cryptogenic cirrhosis. Hepatology 2002; 35:1485-1493.

• Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.

• Robbins CM, Hsu E, Gillevet PM. Sequencing homopolymer tracts and repetitive elements. Biotechniques. 1996;20(5):862-4,866-8.

•. Saadeh S, Younossi ZM, Remer EM et al .The utility of radiological imaging in NAFLD. Gastroenterology 2002; 123:745-50

• Samuel VT, Liu ZX,· Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman G. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease_ J BioI Chem 2004; 279: 32345-32353

• Sanal MG, Sarin SK. Serum Adipokine Profile in Indian Men with Nonalcoholic Steatohepatitis: Serum Adiponectin Is Paradoxically Decreased in Lean Versus Obese. Am J Gastroenterol.l 02 (s2), S215-S248.

139

• Sanal MG. The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol.2008; 14(6):831-44

• Sanyal AJ. Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol HepatoI.2005;2(l):46-53.

• Saradhi M, Kuinar N ,Reddy RC et al. Pregnane and Xenobiotic Receptor (PXR): a promiscuous xenosensor divulging its role in human health and disease. J. Endo Rep. 2006; 1: 1-12

• Satapathy SK,. Garg S, Chauhan R et al. Beneficial Effects of Tumor Necrosis Facto:-a Inhibition by Pentoxifylline on Clinical Biochemical, and Metabolic Parameters of Patients with Nonalcoholic steatohepatitis. Am. J Gastro. 2004; 99: 1946-1952:

• Satapathy SK, Sakhuja P, Malhotra V. Beneficial effects ofpentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non­alcoholic steatohepatitis. J G.astroenterol Hepatol. 2007; 22(5):634-8.

• Saverymuttu ~H et ai. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ 1986; 292: 13-15.

• Scherer PE. Lilly Lecture 2005: Adipose Tissue From Lipid Storage Compartment to Endocrine Organ, Diabetes 2005; 56: 1537-45

• Semenkovich, C. F. Insulin resistance and atherosclerosis. J. Clin. Invest. 2006; 116, 18l3-1822.

• Sethi JK, Hotamisligil GS. The role of TNFa In adipocyte metabolism.Semin. Cell Dev. BioI. 1999;10:19-29

• Sherlock S, James Dooley. Disease of the Liver and Biliary System, 11th Ed

• Shibata R, Ouchi N, Ito M et ai. Adiponectin mediated modulation of hypertrophic signals in the heart. Nature Med.2004; 10 : 1384-90

• Shibata R, Ouchi N, Kihara S et al.Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J BioI Chem. 2004 Jul 2;279(27):28670-4

• Shibata R, Sato K, Pimentel DR et ai. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med. 2005; 11(10):1096-103.

• Sierra-Johnson J et ai. Correspondence between the Adult Treatment Panel III criteria for metabolic syndrome and insulin resistance. Diabetes Care. 2006; 29: 668-672.

• Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O,Meher C, Rao M. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol2004; 75: 76-79

• Songa flY, Kima MR, Lee MJ et al. Oncostatin M decreases adiponectin expression and induces dedifferentiation of adipocytes by JAK3- and MEK­dependent pathways. Int J Biochem Cell BioI. 2007;39(2):439-49.

• Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright eM, Patel

HR, Ahima RS, Lazar MA: The honnone resistin links obesity to diabetes.Nature 200 1;409:307-312

140

• Stewart SH. Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. Arch Intern Med. 2002 ; 162(19):2236-9.

• Stryer L Biochemistry 5th Ed WH Freeman and Company

• Stumvoll M, Tschritter 0, Fritsche A et al. Association of the T-G polymorphism in adiponectin (exon' 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 2002; 51:37- 41

• Sutinen J, Hakkainen AM, Wasterbacka J et al. Increased fat accumulation in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 2002; 16:2183-2193.

• Szmitko PE, Teoh H, Stewart OJ et al.Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ. Physio\. 2007; 292: HI655-HI663.

• Takahashi M, Arita Y, Yamagata K et al. Genomic structure and mutations in adipose-specific gene, adiponectin.Int. 1. Obes. Relat. Metab Disord. 2000 Jul;24(7):816-8

• Takashi Kadowaki and Toshimasa Yamauchi. Adiponectin and Adiponectin Receptors. Endocrine Reviews 2005;26: 439-451

• Takemura Y,Ouchi N,Shibata R et al.Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic

bodies.1 Clin Invest. 2007; 117(2): 375-386

• Tan CE, Ma S, Wai D, Chew SK, Tai ES: Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27: 1182-1186

• Tao L, Gao E, Jiao X et al. Adiponectin cardioprotection after myocardial ischemialreperfusion involves the reduction of oxidative/nitrative stress. Circulation. 2007 Mar 20; 115( 11): 1408-16

• Tatgher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G; Arcaro G: Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006;29: 1325-30

• Targher G, Bertolini L,Pado'vani R et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007; 30(5): 1212-8.

• Targher G. Associations between liver histology and early ·carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. Hepatology 2005; 42: 974-975

• Tatusova T A, Madden TL.Blast 2 sequences - a new tool for comparing protein and nucleotide sequences", FEMS Microbiol Lett. 1999; 174:247-250

• Teli MR, James OFW, Burt AD et a\. The natural history of non-alcoholic fatty liver: a follow up study. Hepatology 1995;22: 1714-19

141

•

•

•

The decode study group. Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. Br J Diabetes Vasc Dis 2005;5: 161-8.

The Exp.ert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160-- 3167.

Tietge UJ, Boker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am. J Physiol Endocrinol Metabol. 2004; 287:E82-E89.

• Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM 1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Human Molecular Genetics.2002; 11 (21) 2607-2614

• Vianey-Saban C, Mousson B, Bertrand C et al. Camitine .palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia. Eur J Pediatrl993; 152: 334-338 [PMID:8482285]

• Vimaleswaran KS, Radha V, Ramya K et al. A novel association of a polymorphism in the first iritron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia In Asian Indians.Human Genetics.2008; 123:599-605

• Wang Y, Xu A, Knight C et al. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. JBC, Vol. 277, No. 22, Issue of May 31, pp. 19521-19529,2002

• Wang Y,Lam JB, Lam KSL.Adiponectin Modulates the Glycogen Synthase Kinase-3BIB-Catenin Signaling Pathway and Attenuates Mammary Tumorigenesis of MDA-MB-231 Cells in Nude Mice. Cancer Res 2006; 66(23): 11462-70

• Whincup PH, Gilg JA, Papacosta. 0 et aI, Early evidence of ethnic differences in cardiovascular risk; cross sectional comparison of British South Asian and White children. BMJ 2002; 324:635-638

• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363, 157-163.

• Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 1993; 341: 407-408 [PMID: 8094173]

• Wild.S, Roglic.G, Green.A, Sicree.R, King.H. Global prevalence of Diabetes: Estimates for year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.

142

• Wolf A.M, Wolf 0, Avila MA, Moschen AR, Berasain C, Enrich B, Rumpold H, Tilg H. Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. 1. Hepatol.2006; 44:537-543.

• Wong GW, Hug C, Tsao TS, Lodish HF. A family of Acrp30 ladiponectin structural and functional paralogs. PNAS 2004; 101 (28): 10302-07

• World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on ObesitY. Geneva: WHO, 1998.

• WPRO-World Health Organization, IASO International Association for the Study of Obesity, International Obesity Task Force; The Asia-Pacific Perspective: Redefining Obesity and its treatment-Feb.2000.

• Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper Gl. The fat derived honnone adiponectin alleviates alcoholic and nonalcoholic fatty liver disease in mice. 1 Clin Invest 2003;112:91-100.

• Yajnik CS, Fall CHD, Vaidya U et al. Fetal growth and glucose and insulin metabolism in four year-old Indian children. Diabet Med 1995; 12: 330-6.

• Yamaguchi N, Kukita T, Li Yl. Adiponectin inhibits induction of TNF­alphaiRANKL-stimulated NF A Tc 1 via the AMPK signaling. FEBS Lett. 2008 Feb 6;582(3):451-6.

• Yamamoto Y, Hirose H, Saito I et al. Correlation of adipocyte derived protein adiponectin with insulin resistance index and serum high density lipoprotein- cholesterol, independent of body mass index, in Japanese population. Clinical Sciences 2002; 103: 137-142.

• Yamauchi MD, Moss KA; Bovenkerk lE. Regulation of Adiponectin Expression in Human Adipocytes: Effects of Aiposity, Gluco'corticoids, and Tumor Necrosis Factor-a. Obes Res. 2005; 13:662- 669.

• Yamauchi T, Kaman 1, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003 ;423(6941):762-9.

• Yang. H, Zhang R, Mu H et al. Adiponectin promotes endothelial cell differentiation from human peripheral CDI4+ monocytes in vitro. 1 Cell Mol Med. 2006 Apr-lun; 10(2):459-69

• Yang Q, Graham TE, Mody N, Preitner F, Peroni 00, Zabolotny 1M, KotaniK, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to

---- -insulin resistance in obesity and type 2 diabetes. Nature 436:356 -362,2005

• Yang, R. Z. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. 1. Physiol. Endocrinol. Metab. 2006;290, E1253-E1261

• You M, Fischer M, Deeg MA, and Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J BioI Chern 2002; 277: 29342-29347

• You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). 1 Bioi Chern. 2002;277:29342-7

143

• Young B, Lowe JS, Stevens A, Heath JW. Wheater's Functional Histology, 5th Ed.

• Zhang Y, Proenca R, MaffeI M, Barone M, Leopold L, Friedman JM:Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425- 432

• Zhou J, Zhai Y, Mu Y et al. A novel PXR-mediated and SREBP­independent lipoge,nic pathway. J BioI Chern. 2006;281: 150 13-20

144